NO983943L - Anvendelse av inhibitorer av natrium-hydrogen-utvekslere for fremstilling av et legemiddel for behandling av sykdommer forÕrsaket av protozoer - Google Patents

Anvendelse av inhibitorer av natrium-hydrogen-utvekslere for fremstilling av et legemiddel for behandling av sykdommer forÕrsaket av protozoer

Info

Publication number
NO983943L
NO983943L NO983943A NO983943A NO983943L NO 983943 L NO983943 L NO 983943L NO 983943 A NO983943 A NO 983943A NO 983943 A NO983943 A NO 983943A NO 983943 L NO983943 L NO 983943L
Authority
NO
Norway
Prior art keywords
protozoa
medicament
inhibitors
sodium
manufacture
Prior art date
Application number
NO983943A
Other languages
English (en)
Other versions
NO983943D0 (no
NO320368B1 (no
Inventor
Hans Jochen Lang
Michael Lanzer
Jochen Wiesner
Cecilia Sanchez
Stefan Wuensch
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of NO983943D0 publication Critical patent/NO983943D0/no
Publication of NO983943L publication Critical patent/NO983943L/no
Publication of NO320368B1 publication Critical patent/NO320368B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19983943A 1997-08-28 1998-08-27 Anvendelse av inhibitorer av natrium-hydrogen-utvekslere for fremstilling av et medikament for behandling og profylakse av sykdommer forarsaket av protozoer NO320368B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737463A DE19737463A1 (de) 1997-08-28 1997-08-28 Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden

Publications (3)

Publication Number Publication Date
NO983943D0 NO983943D0 (no) 1998-08-27
NO983943L true NO983943L (no) 1999-03-01
NO320368B1 NO320368B1 (no) 2005-11-28

Family

ID=7840411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983943A NO320368B1 (no) 1997-08-28 1998-08-27 Anvendelse av inhibitorer av natrium-hydrogen-utvekslere for fremstilling av et medikament for behandling og profylakse av sykdommer forarsaket av protozoer

Country Status (25)

Country Link
US (1) US6114393A (no)
EP (1) EP0901788A3 (no)
JP (1) JPH11171792A (no)
KR (1) KR100567144B1 (no)
CN (1) CN1244322C (no)
AR (1) AR013949A1 (no)
AU (1) AU738599B2 (no)
BR (1) BR9803243A (no)
CA (1) CA2246407A1 (no)
CZ (1) CZ296815B6 (no)
DE (1) DE19737463A1 (no)
HR (1) HRP980468A2 (no)
HU (1) HU225583B1 (no)
ID (1) ID20794A (no)
IL (1) IL125946A0 (no)
MY (1) MY137406A (no)
NO (1) NO320368B1 (no)
NZ (1) NZ331566A (no)
PL (1) PL191267B1 (no)
RU (1) RU2225726C2 (no)
SG (1) SG74074A1 (no)
SK (1) SK285457B6 (no)
TR (1) TR199801669A3 (no)
TW (1) TW592690B (no)
ZA (1) ZA987781B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
AU783685B2 (en) * 1999-12-23 2005-11-24 Pfizer Products Inc. Hydrogel-driven drug dosage form
US7375138B2 (en) 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
SI3649109T1 (sl) * 2017-07-04 2021-11-30 Sanofi Etinilne spojine, njihova priprava in njihova terapevtska uporaba za zdravljenje malarije

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026402A (en) * 1961-12-12 1966-04-20 Wellcome Found Substituted guanidines
GB1336871A (en) * 1970-01-02 1973-11-14 Wellcome Found Method for preparing biologically active substituted amidines
US4088780A (en) * 1974-05-15 1978-05-09 Bayer Aktiengesellschaft Substituted phenylguanidines and processes for their preparation and use
US4032655A (en) * 1974-05-15 1977-06-28 Bayer Aktiengesellschaft Phenylguanidines useful as anthelmintic agents
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
US4732907A (en) * 1983-04-14 1988-03-22 Pfizer Inc. Antiprotozoal diamidines and bis-imidazoline
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
IN172842B (no) * 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
US5352667A (en) * 1991-11-22 1994-10-04 Ofer Lider Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
PT832094E (pt) * 1995-06-07 2004-06-30 Genaera Corp Compostos de aminoesterol uteis como inibidores do permutador sodio/protao )nhe) metodos e composicoes farmaceuticas empregando estes inibidores e processos para avaliacao da eficacia inibidora de nhe dos compostos
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
CN1209994A (zh) 1999-03-10
HU9801925D0 (en) 1998-10-28
HRP980468A2 (en) 1999-06-30
HUP9801925A3 (en) 2004-11-29
PL191267B1 (pl) 2006-04-28
KR100567144B1 (ko) 2006-11-30
AU738599B2 (en) 2001-09-20
AR013949A1 (es) 2001-01-31
TR199801669A2 (xx) 1999-03-22
HK1018589A1 (en) 1999-12-30
IL125946A0 (en) 1999-04-11
NO983943D0 (no) 1998-08-27
AU8189498A (en) 1999-03-11
CN1244322C (zh) 2006-03-08
NZ331566A (en) 2001-03-30
SK117498A3 (en) 1999-03-12
KR19990023905A (ko) 1999-03-25
RU2225726C2 (ru) 2004-03-20
PL328265A1 (en) 1999-03-01
US6114393A (en) 2000-09-05
SK285457B6 (sk) 2007-02-01
CZ296815B6 (cs) 2006-06-14
EP0901788A3 (de) 2004-01-02
CZ272998A3 (cs) 1999-03-17
HU225583B1 (en) 2007-03-28
MY137406A (en) 2009-01-30
EP0901788A2 (de) 1999-03-17
HUP9801925A1 (hu) 2000-02-28
TW592690B (en) 2004-06-21
SG74074A1 (en) 2000-07-18
ZA987781B (en) 1999-05-27
DE19737463A1 (de) 1999-03-04
TR199801669A3 (tr) 1999-03-22
JPH11171792A (ja) 1999-06-29
NO320368B1 (no) 2005-11-28
ID20794A (id) 1999-03-04
CA2246407A1 (en) 1999-02-28
BR9803243A (pt) 2000-03-21

Similar Documents

Publication Publication Date Title
CY2013020I2 (el) Η χρηση μιας ενωσης ινγκενανης για την κατασκευη ενος φαρμακου για την θεραπεια του καρκινου
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
FI971412A7 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
DK0769017T3 (da) Terapeutiske forbindelser
EE9800194A (et) Uued valuvaigistava toimega ühendid
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
FI954007A0 (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
PT752246E (pt) Kapa-opiatos para doencas inflamatorias dos intestinos
EE9900029A (et) Amiinide kasutamine kasvajarakkude paljunemise takistamiseks mõeldud ravimite tootmiseks
ID21534A (id) Konstruksi asam nukleat untuk terapi gen dimana aktifitasnya dipengaruhi oleh inhibitor kinase yang tergantung pada siklin
NO20012976D0 (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
NO20010953D0 (no) En fremgangsmÕte for behandling av stafylokokkal sykdom
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
ITMI20001051A0 (it) Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
NO20021937L (no) Fremgangsmåte for administrering av en fosfodiesterase 4- hemmer
IT1277904B1 (it) Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO983943D0 (no) Anvendelse av inhibitorer av natrium-hydrogen-utveksler for fremstilling av et legemiddel for behandling av sykdommer forårsaket av protozoer
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
NO990949D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
ZA988066B (en) The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart
NO984430D0 (no) Anvendelse av en inhibitor av Na+/H+-utveksler for fremstilling av medikament for behandling av profylakser av sykdommer i sentralnervesystemet